T Daladimos

Learn More
BACKGROUND Recurrent or metastatic cervical cancer represents an aggressive malignancy with a high rate of locoregional and distant failure. Therefore, we evaluated the three-drug combination of paclitaxel-ifosfamide-cisplatin (TIP). METHODS Systemic chemotherapy-naive patients with advanced metastatic/relapsed cervical cancer and a World Health(More)
BACKGROUND Malignant mixed Mullerian tumours (MMMTs) of the uterus and adnexa represent aggressive gynaecologic malignancies with a high rate of loco-regional and distant failure. For that reason, we evaluated the paclitaxel-ifosfamide-carboplatin (TICb) combination in patients with advanced MMMTs. METHODS Female patients with advanced MMMTs, WHO-PS 0-2,(More)
  • 1